Exicure Operating Company

Calculating rank

USPTO Granted Patents = 4

Trademarks = 1

Forward Citations = 6

Loading Chart...

8 inventors (with patents filed for the assignee):

Richard Kang (4 out of 7 patents)

Subbarao Nallagatla (3 out of 6 patents)

Aleksandar Filip Radovic-Moreno (2 out of 23 patents)

4. Sergei M Gryaznov (2 out of 84 patents)

5. Christopher C Mader (2 out of 10 patents)

6. Ekambar R Kandimalla (2 out of 78 patents)

7. Scott Mix (1 out of 2 patents)

8. Bart Anderson (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11957788 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications (2024-04-16),

2. 11866700 - Liposomal spherical nucleic acid (SNA) constructs presenting antisense oligonucleotides (ASO) for specific knockdown of interleukin 17 receptor mRNA (2024-01-09),

3. 11696954 - Synthesis of spherical nucleic acids using lipophilic moieties (2023-07-11),

4. 11123294 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications (2021-09-21),

Company Overview

Exicure Operating Company is a clinical-stage biotechnology company developing therapeutics for skin diseases and cancer. They use their proprietary SNA technology to design and develop novel treatments that target specific cells in the body. Their pipeline includes potential treatments for psoriasis, alopecia, and various types of cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

4 Patents

#667 in Chicago, IL

#2,844 in Illinois

#60,778 in US

Chicago, IL, United States of America